https://www.marketscreener.com/news/summit-therapeutics-announces-clinical-trial-collaboration-with-gsk-plc-to-evaluate-ivonescimab-in-c-ce7e58dbdd8efe23
Summit Therapeutics Inc. announced it has entered into a clinical trial collaboration with GSK plc to evaluate ivonescimab, a novel, investigational PD-1 /VEGF...
summit therapeuticsclinical trialgsk plcannouncescollaboration
https://menafn.com/1110697180/Relay-Therapeutics-To-Participate-In-Guggenheim-Emerging-Outlook-Biotech-Summit-2026
Relay Therapeutics To Participate In Guggenheim Emerging Outlook: Biotech Summit 2026. CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics,...
relaytherapeuticsparticipateguggenheimemerging
https://www.businesswire.com/news/home/20260109884241/en/Summit-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective...
summit therapeuticsreportsinducementgrantsnasdaq
https://www.globenewswire.com/news-release/2019/04/30/1813164/0/en/DiaMedica-Therapeutics-to-Present-at-CKD3-Kidney-Summit-Meeting.html
MINNEAPOLIS, April 30, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced that...
therapeuticspresentkidneysummit
https://capital.com/de-de/markets/shares/summit-therapeutics-inc-aktienkurs-2
Summit Therapeutics Inc (ticker: SMMT) Echtzeit-Aktienwert, Investment, historische Daten, Rating und Finanzmarktinformationen bei Capital.com.
summit therapeuticsjetzt tradenincsmmtaktie
https://www.macrotrends.net/stocks/charts/SMMT/summit-therapeutics/balance-sheet
Ten years of annual and quarterly balance sheets for Summit Therapeutics (SMMT). The balance sheet is a financial report that shows the assets of a business...
summit therapeuticsbalance sheetsmmtmacrotrends
https://www.ainvest.com/news/summit-therapeutics-smmt-us-rose-more-than-50-before-market-opened-on-progress-in-cancer-drugs-2409101088ed7f69c675b813/
Summit Therapeutics (SMMT.US) rose more than 50% before the market opened on progress in cancer drugs
summit therapeuticssmmtusrose
https://glp-1-based-therapeutics.com/
An industry-focused forum dedicated to overcoming clinical and commercial challenges of GLP-1s in Obesity, MASH, Neuroscience and more
glpbasedtherapeuticssummit
https://www.prnewswire.com/news-releases/second-genome-to-present-at-the-jefferies-microbiome-based-therapeutics-summit-301269346.html
/PRNewswire/ -- Second Genome, a tech-enabled biotechnology company that extracts microbial genetic insights to make transformational precision therapies and...
second genomepresentjefferiesmicrobiomebased
https://menafn.com/1110694518/Akebia-Therapeutics-To-Present-At-The-Guggenheim-Emerging-Outlook-Biotech-Summit-2026
Akebia Therapeutics To Present At The Guggenheim Emerging Outlook: Biotech Summit 2026. CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics...
akebiatherapeuticspresentguggenheimemerging
https://capital.com/de-int/markets/shares/summit-therapeutics-inc-aktienkurs-2
Summit Therapeutics Inc (ticker: SMMT) Echtzeit-Aktienwert, Investment, historische Daten, Rating und Finanzmarktinformationen bei Capital.com.
summit therapeuticsjetzt tradenincsmmtaktie
https://www.macrotrends.net/stocks/charts/SMMT/summit-therapeutics/ebitda-margin
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Summit Therapeutics (SMMT) over the last 10 years....
summit therapeuticsebitda marginsmmtmacrotrends